Frontlight ResearchEarly access
Trial site
Texas Oncology - Dallas
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Endometrial cancer2 trials
- Gastric and oesophageal cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Neuroendocrine tumours1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- and 2 more
- Phase
- Phase 34 trials
- Phase 12 trials
- Status
- Active, not recruiting6 trials
- Lead sponsor
- Camurus AB1 trial
- Karyopharm Therapeutics Inc1 trial
- Revolution Medicines, Inc.1 trial
- Summit Therapeutics1 trial
- Tizona Therapeutics, Inc1 trial
- and 1 more
Running trials
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Active, not recruiting
Active, not recruiting
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer
Active, not recruiting
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Active, not recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026